key: cord-0843904-c82agjmb authors: Kazawa, Kana; Kubo, Tatsuhiko; Ohge, Hiroki; Akishita, Masahiro; Ishii, Shinya title: Preparedness guide for people with dementia and caregivers in COVID‐19 pandemic date: 2021-05-09 journal: Geriatr Gerontol Int DOI: 10.1111/ggi.14178 sha: b646a481471f42fa1f893011f0af108fecd3e224 doc_id: 843904 cord_uid: c82agjmb nan (BPSD). 4, 5 Second, COVID-19 infection may present with atypical signs and symptoms in older people, which may reduce the chances of early detection and treatment. It is particularly problematic for older PWD because they may not be able to complain about their symptoms clearly. Third, restriction measures for COVID-19 may have adverse effects on the PWD. They need support from caregivers and long-term care insurance services to meet their daily needs and maintain their daily routines, including exercise and social interaction. Therefore, shutting down or reducing these services to control the spread of infection, combined with social distancing, may deprive them of cognitive and physical stimulation, leading to modulation of their circadian rhythms and worsening BPSD. 6, 7 The online self-administered questionnaire survey of care managers conducted in June and July Figure 1 The impact of COVID-19 on people with dementia. A questionnaire survey of the care managers was conducted. Care managers are the key professionals in Japan's long-term care insurance system, who develop care plans and coordinate services provided to those who need care. The severity of dementia was classified as follows based on "Criteria for determination of the daily life independence level of the elderly with dementia "defined by Ministry of Health, Labour and Welfare (Japan). There are five levels in the original levels (Grades I-IV, M). Mild to moderate dementia (the original level Grade II); Symptoms, behavior or difficulty in communication that interfere the person's daily life are observed to some degree, but can live independently if someone will look after. Severe dementia (Grade III or higher); Symptoms, behavior or difficulty in communication that interfere with the person's daily life are observed once in a while or frequently, and requires care. 2020 by Hiroshima University and the Japan Geriatrics Society corroborated the unfavorable effects of restriction measures (Fig. 1) . 8 Of the 751 care managers who cooperated in the survey, 286 (38.1%) answered that home-and nursing facility-dwelling PWD they cared for had been negatively affected by COVID-19 restriction measures. The decline in cognitive and physical function and the onset or worsening of BPSD were most commonly observed as adverse effects. This survey also demonstrated that in the cases of shutting down or reducing long-term care insurance services, 72.6% of care managers answered that caregivers (families) took care of PWD temporarily instead of the home care services. It should be noted that this led to a significant increase in caregiver burden. The most common consequence reported was taking time off from work (40.1%), followed by depressive tendency (27.5%), physical burden (21.7%) and financial burden (11.4%). Thus, the COVID-19 restriction measures have severe mental, physical and social impacts for PWD and their caregivers and need to be addressed. The provision of appropriate and individualized information about precautions and preparedness for the spread of infection is urgently needed. It can lead to proper self-care and reduce the fear and anxiety of caregivers. 9 It might even contribute to the stabilization of the physical and mental states of PWD. Based on the survey mentioned above, a preparedness guide for PWD and caregivers was developed by Hiroshima University, Alzheimer's Association Japan, Hiroshima Branch, and the COVID-19 response team of the Japan Geriatrics Society. 10 The guide provides information on COVID-19 and action plans according to their cognitive and physical status based on the following three points: 1. Information on COVID-19 and measures of prevention of infection in people with various stages of dementia, e.g., infection control measures for persons who cannot wash their hands or wear masks. 2. How to prepare for the spread of COVID-19, e.g., preparing for the cessation or reduction of long-term care services. 3. Prevention of deterioration of cognitive and physical functions in PWD resulting from COVID-19 restriction measures, e.g., the importance of social interaction, social support and exercises, and how to incorporate these activities into their daily lives. This guide is freely available on the Hiroshima University website (http://inclusivesociety.jp/project.html#01) and is hoped to help PWD properly implement COVID-19 restriction measures while avoiding their adverse effects and minimizing the burden on caregivers. Clinical presentation of COVID19 in dementia patients Clinical characteristics and prognostic factors in COVID-19 patients aged ≥80 years Neurological diseases as mortality predictive factors for patients with COVID-19: a retrospective cohort study Anticipating and mitigating the impact of the COVID-19 pandemic on Alzheimer's disease and related dementias Effectively caring for individuals with behavioral and psychological symptoms of dementia during the COVID-19 pandemic Neuropsychiatric symptoms in elderly with dementia during COVID-19 pandemic: definition, treatment, and future directions The impact of COVID-19 infection and enforced prolonged social isolation on neuropsychiatric symptoms in older adults with and without dementia: a review Graduate School of Biomedical and Health Sciences, Hiroshima University. Findings on the impact of COVID-19 pandemic on people with dementia and caregivers [online material Living with dementia: increased level of caregiver stress in times of COVID-19 Department of Medicine for Integrated Approach to Social Inclusion, Graduate School of Biomedical and Health Sciences, Hiroshima University. Preparedness guide in COVID-19 pandemic for people with dementia and caregivers [online material We thank the care managers for answering the questionnaires and the COVID-19 response team of the Japan Geriatrics Society for their cooperation with the survey. We would also like to thank the Department of Infectious Diseases, Hiroshima Hospital, Department of Public Health and Health Policy, Hiroshima University, Alzheimer's Association Japan, Hiroshima Branch, and the COVID-19 response teams of the Japan Geriatrics Society for the development of this guide.